Table 2.

Results of Regression Models Estimating the Risk of Severity Outcomes in Children and Adults Hospitalized in Quebec With Human Coronavirus Versus Influenza Infections (2011–2012 to 2018–2019)

HCoV vs Influenza Infectiona
OutcomePatients, No.aCrude OR/RR (95% CI)Adjusted OR/RR (95% CI)Adjustment Variablesb
Children
 LOSc
HCoV and influenza coinfections included as covariate3721.12 (.96–1.30)1.12 (.94– 1.32)Age,d sex, year,d comorbid condition, coinfection,e vaccination
  Restricted to monoinfections2110.90 (.67–1.20)0.90 (.60–1.36)Age, sex, year,d comorbid condition, vaccinationd
 Pneumoniaf
HCoV and influenza coinfections included as covariate3721.11 (.68–1.82)1.08 (.69–1.69)Age,d sex, year,d comorbid condition, coinfection,d,e vaccinationd
  Restricted to monoinfections2110.47 (.16–1.42)Not availableAdjusted model did not converge
Adults
 LOSc
HCoV and influenza coinfections included as covariate17191.04 (.91–1.18)1.07 (.89–1.29)Age,d sex, year,d admitted from LTCF,d comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15611.02 (.89–1.18)1.05 (.89–1.25)Age,d sex, year,d admitted from LTCF,d comorbid condition,d influenza vaccination
 Pneumoniaf
HCoV and influenza coinfections included as covariate17201.08 (.78–1.48)1.14 (.75–1.71)Age,d sex,d year,d admitted from LTCF,d comorbid condition,d coinfection,e influenza vaccinationd
  Restricted to monoinfections15621.14 (.81–1.61)1.17 (.76–1.81)Age,d sex,d year,d admitted from LTCF,d comorbid condition, influenza vaccinationd
 ICU admissionf
HCoV and influenza coinfections included as covariate17211.16 (.69–1.95)0.96 (.55–1.68)Age,d sex,d year,d admitted from LTCF, comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15631.16 (.67–2.01)0.98 (.57–1.69)Age,d sex,d year,d admitted from LTCF, comorbid condition,d influenza vaccination
 In-hospital deathf
HCoV and influenza coinfections included as covariate17211.52 (.78–2.93)1.42 (.92–2.17)Age,d sex, year,d admitted from LTCF, comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15631.41 (.68–2.90)1.27 (.83–1.95)Age,d sex, year,d admitted from LTCF, comorbid condition,d influenza vaccination
HCoV vs Influenza Infectiona
OutcomePatients, No.aCrude OR/RR (95% CI)Adjusted OR/RR (95% CI)Adjustment Variablesb
Children
 LOSc
HCoV and influenza coinfections included as covariate3721.12 (.96–1.30)1.12 (.94– 1.32)Age,d sex, year,d comorbid condition, coinfection,e vaccination
  Restricted to monoinfections2110.90 (.67–1.20)0.90 (.60–1.36)Age, sex, year,d comorbid condition, vaccinationd
 Pneumoniaf
HCoV and influenza coinfections included as covariate3721.11 (.68–1.82)1.08 (.69–1.69)Age,d sex, year,d comorbid condition, coinfection,d,e vaccinationd
  Restricted to monoinfections2110.47 (.16–1.42)Not availableAdjusted model did not converge
Adults
 LOSc
HCoV and influenza coinfections included as covariate17191.04 (.91–1.18)1.07 (.89–1.29)Age,d sex, year,d admitted from LTCF,d comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15611.02 (.89–1.18)1.05 (.89–1.25)Age,d sex, year,d admitted from LTCF,d comorbid condition,d influenza vaccination
 Pneumoniaf
HCoV and influenza coinfections included as covariate17201.08 (.78–1.48)1.14 (.75–1.71)Age,d sex,d year,d admitted from LTCF,d comorbid condition,d coinfection,e influenza vaccinationd
  Restricted to monoinfections15621.14 (.81–1.61)1.17 (.76–1.81)Age,d sex,d year,d admitted from LTCF,d comorbid condition, influenza vaccinationd
 ICU admissionf
HCoV and influenza coinfections included as covariate17211.16 (.69–1.95)0.96 (.55–1.68)Age,d sex,d year,d admitted from LTCF, comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15631.16 (.67–2.01)0.98 (.57–1.69)Age,d sex,d year,d admitted from LTCF, comorbid condition,d influenza vaccination
 In-hospital deathf
HCoV and influenza coinfections included as covariate17211.52 (.78–2.93)1.42 (.92–2.17)Age,d sex, year,d admitted from LTCF, comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15631.41 (.68–2.90)1.27 (.83–1.95)Age,d sex, year,d admitted from LTCF, comorbid condition,d influenza vaccination

Abbreviations: CI, confidence interval; HCoV, common human coronavirus; ICU, intensive care unit; LOS, length of stay; LTCF, long-term care facility; OR, odds ratio; RR, risk ratio for LOS.

aThirty-nine patients with coronavirus-influenza coinfection were excluded from the analyses.

bCategories are as follows: age in children: 6–23 months, 2–4 years, or 5–17 years; age in adults, 18–64, 65–74, 75–84, or ≥85 years; admission: community-dwelling versus admission from LTCF/other; comorbid conditions in in children: present or absent; comorbid conditions in adults: none, cardiovascular disease, chronic respiratory disease, both cardiovascular and respiratory disease, or other comorbid condition (obesity, diabetes, chronic renal disease, immunodeficiency, or neurological disease); influenza vaccination status: vaccinated, not vaccinated or unknown vaccination status or timing.

cAnalyses performed using generalized estimating equations with exchangeable correlation matrix for hospital of recruitment, negative binomial distribution, and log link.

dSignificant association with outcome (P < .05).

eCoinfection other than HCoV/influenza.

fAnalyses performed using generalized estimating equations with exchangeable correlation matrix for hospital of recruitment, binomial distribution, and logit link.

Table 2.

Results of Regression Models Estimating the Risk of Severity Outcomes in Children and Adults Hospitalized in Quebec With Human Coronavirus Versus Influenza Infections (2011–2012 to 2018–2019)

HCoV vs Influenza Infectiona
OutcomePatients, No.aCrude OR/RR (95% CI)Adjusted OR/RR (95% CI)Adjustment Variablesb
Children
 LOSc
HCoV and influenza coinfections included as covariate3721.12 (.96–1.30)1.12 (.94– 1.32)Age,d sex, year,d comorbid condition, coinfection,e vaccination
  Restricted to monoinfections2110.90 (.67–1.20)0.90 (.60–1.36)Age, sex, year,d comorbid condition, vaccinationd
 Pneumoniaf
HCoV and influenza coinfections included as covariate3721.11 (.68–1.82)1.08 (.69–1.69)Age,d sex, year,d comorbid condition, coinfection,d,e vaccinationd
  Restricted to monoinfections2110.47 (.16–1.42)Not availableAdjusted model did not converge
Adults
 LOSc
HCoV and influenza coinfections included as covariate17191.04 (.91–1.18)1.07 (.89–1.29)Age,d sex, year,d admitted from LTCF,d comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15611.02 (.89–1.18)1.05 (.89–1.25)Age,d sex, year,d admitted from LTCF,d comorbid condition,d influenza vaccination
 Pneumoniaf
HCoV and influenza coinfections included as covariate17201.08 (.78–1.48)1.14 (.75–1.71)Age,d sex,d year,d admitted from LTCF,d comorbid condition,d coinfection,e influenza vaccinationd
  Restricted to monoinfections15621.14 (.81–1.61)1.17 (.76–1.81)Age,d sex,d year,d admitted from LTCF,d comorbid condition, influenza vaccinationd
 ICU admissionf
HCoV and influenza coinfections included as covariate17211.16 (.69–1.95)0.96 (.55–1.68)Age,d sex,d year,d admitted from LTCF, comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15631.16 (.67–2.01)0.98 (.57–1.69)Age,d sex,d year,d admitted from LTCF, comorbid condition,d influenza vaccination
 In-hospital deathf
HCoV and influenza coinfections included as covariate17211.52 (.78–2.93)1.42 (.92–2.17)Age,d sex, year,d admitted from LTCF, comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15631.41 (.68–2.90)1.27 (.83–1.95)Age,d sex, year,d admitted from LTCF, comorbid condition,d influenza vaccination
HCoV vs Influenza Infectiona
OutcomePatients, No.aCrude OR/RR (95% CI)Adjusted OR/RR (95% CI)Adjustment Variablesb
Children
 LOSc
HCoV and influenza coinfections included as covariate3721.12 (.96–1.30)1.12 (.94– 1.32)Age,d sex, year,d comorbid condition, coinfection,e vaccination
  Restricted to monoinfections2110.90 (.67–1.20)0.90 (.60–1.36)Age, sex, year,d comorbid condition, vaccinationd
 Pneumoniaf
HCoV and influenza coinfections included as covariate3721.11 (.68–1.82)1.08 (.69–1.69)Age,d sex, year,d comorbid condition, coinfection,d,e vaccinationd
  Restricted to monoinfections2110.47 (.16–1.42)Not availableAdjusted model did not converge
Adults
 LOSc
HCoV and influenza coinfections included as covariate17191.04 (.91–1.18)1.07 (.89–1.29)Age,d sex, year,d admitted from LTCF,d comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15611.02 (.89–1.18)1.05 (.89–1.25)Age,d sex, year,d admitted from LTCF,d comorbid condition,d influenza vaccination
 Pneumoniaf
HCoV and influenza coinfections included as covariate17201.08 (.78–1.48)1.14 (.75–1.71)Age,d sex,d year,d admitted from LTCF,d comorbid condition,d coinfection,e influenza vaccinationd
  Restricted to monoinfections15621.14 (.81–1.61)1.17 (.76–1.81)Age,d sex,d year,d admitted from LTCF,d comorbid condition, influenza vaccinationd
 ICU admissionf
HCoV and influenza coinfections included as covariate17211.16 (.69–1.95)0.96 (.55–1.68)Age,d sex,d year,d admitted from LTCF, comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15631.16 (.67–2.01)0.98 (.57–1.69)Age,d sex,d year,d admitted from LTCF, comorbid condition,d influenza vaccination
 In-hospital deathf
HCoV and influenza coinfections included as covariate17211.52 (.78–2.93)1.42 (.92–2.17)Age,d sex, year,d admitted from LTCF, comorbid condition,d coinfection,e influenza vaccination
  Restricted to monoinfections15631.41 (.68–2.90)1.27 (.83–1.95)Age,d sex, year,d admitted from LTCF, comorbid condition,d influenza vaccination

Abbreviations: CI, confidence interval; HCoV, common human coronavirus; ICU, intensive care unit; LOS, length of stay; LTCF, long-term care facility; OR, odds ratio; RR, risk ratio for LOS.

aThirty-nine patients with coronavirus-influenza coinfection were excluded from the analyses.

bCategories are as follows: age in children: 6–23 months, 2–4 years, or 5–17 years; age in adults, 18–64, 65–74, 75–84, or ≥85 years; admission: community-dwelling versus admission from LTCF/other; comorbid conditions in in children: present or absent; comorbid conditions in adults: none, cardiovascular disease, chronic respiratory disease, both cardiovascular and respiratory disease, or other comorbid condition (obesity, diabetes, chronic renal disease, immunodeficiency, or neurological disease); influenza vaccination status: vaccinated, not vaccinated or unknown vaccination status or timing.

cAnalyses performed using generalized estimating equations with exchangeable correlation matrix for hospital of recruitment, negative binomial distribution, and log link.

dSignificant association with outcome (P < .05).

eCoinfection other than HCoV/influenza.

fAnalyses performed using generalized estimating equations with exchangeable correlation matrix for hospital of recruitment, binomial distribution, and logit link.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close